SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories reports 91.52% fall in Q1 net profit

08 May 2013 Evaluate

Ranbaxy Laboratories has reported results for the first quarter ended March 31, 2013.

The company has reported a fall of 91.52% in its net profit at Rs 70.14 crore in Q4FY13 as compared to net profit of Rs 827.23 crore in the same quarter previous year.  Total income of the company has decreased by 25.32% to Rs 1433.96 crore as compared to Rs 1920.16 crore in corresponding quarter last year.

On consolidated basis, the company has reported a fall of 89.91% in its net profit at Rs 125.75 crore in Q4FY13 as compared to net profit of Rs 1246.76 crore in the same quarter previous year.  Total income of the company has decreased by 33.29% to Rs 2562.96 crore as compared to Rs 3842.02 crore in corresponding quarter last year.

Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×